Dogmas, challenges, and promises in phase III allergen immunotherapy studies()

The concept of treatment of an allergy with the offending allergen was introduced more than a century ago. Allergen immunotherapy (AIT) is the only disease modifying treatment of allergic diseases caused by inhalational allergens and insect venoms. Despite this, only few AIT products have reached li...

Descripción completa

Detalles Bibliográficos
Autores principales: De Kam, Pieter-Jan, Kramer, Matthias F., Shamji, Mohamed H., Oluwayi, Kemi, Heath, Matthew D., Jensen-Jarolim, Erika, Berger, Markus H., Berger, Uwe E., Graessel, Anke, Sellwood, Fiona, Zielen, Stefan, Vogelberg, Christian, Zieglmayer, Petra, Mösges, Ralph, Klimek, Ludger, DuBuske, Lawrence M., Shreffler, Wayne G., Bernstein, Jonathan A., Kündig, Thomas M., Skinner, Murray A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487954/
https://www.ncbi.nlm.nih.gov/pubmed/34659627
http://dx.doi.org/10.1016/j.waojou.2021.100578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487954/
https://www.ncbi.nlm.nih.gov/pubmed/34659627
http://dx.doi.org/10.1016/j.waojou.2021.100578

Ejemplares similares